Home › NDC Lookup › RxCUI directory › RxCUI 2738995

Cobicistat 90 MG / darunavir 600 MG Tablet for Oral Suspension — RxCUI 2738995

RxNorm drug concept · Semantic clinical drug
RxCUI 2738995 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2738995
Official nameCobicistat 90 MG / darunavir 600 MG Tablet for Oral Suspension
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asdarunavir 600 MG (as darunavir ethanolate ) / cobicistat 90 MG Tablet for Oral Suspension
FDA products mapped3
Package NDCs mapped2
Reported Medicaid activity (SDUD)32,250 prescriptions · 47 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Darunavir: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • No — darunavir really does need ritonavir to work properly. On its own, your body breaks darunavir down too quickly for it to control HIV. Ritonavir slows that breakdown, which kee...
  • Why do I have to take ritonavir with my darunavir — can't I just take darunavir alone?
  • Yes, it really does. Taking darunavir tablets with food increases how much the drug gets into your bloodstream by about 40% compared to taking it on an empty stomach. So the instru...
  • Does it matter whether I take darunavir with food?
📖 Read our full Darunavir guide →

🕸️ Concept Web — How Cobicistat 90 MG / darunavir 600 MG Tablet for O... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Cobicistat 90 MG / darunavir 600 MG Tablet for Oral Suspension RxCUI 2738995

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 3

    The active substance itself — no strength, form, or brand attached yet.

    • Cobicistat 1306284
    • Darunavir 460132
    • Cobicistat / darunavir 1598380
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Prezcobix 1600705
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Cobicistat / darunavir Tablet for Oral Suspension 2738994
    • Cobicistat / darunavir Oral Liquid Product 2738993
    • Cobicistat / darunavir Oral Product 1600701
    • Cobicistat / darunavir Tablet for Oral Suspension [Prezcobix] 2738998
    • Prezcobix Oral Liquid Product 2738997
    • Prezcobix Oral Product 1600708
    • Tablet for Oral Suspension 1861409
    • Oral Liquid Product 1151137
    • +1 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 16 of 17 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Cobicistat 90 MG SCDC · 2719617
  • Darunavir 600 MG SCDC · 670025
  • Cobicistat / darunavir Tablet for Oral Suspension SCDF · 2738994
  • Cobicistat / darunavir Oral Liquid Product SCDG · 2738993
  • Cobicistat / darunavir Oral Product SCDG · 1600701

Brand-Name Concepts

📦 FDA Products & Package NDCs

3 products · 2 package NDCs
2 package NDCs map to RxCUI 2738995 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
59676-0575-30 30 TABLET, FILM COATED in 1 BOTTLE (59676-575-30) PREZCOBIX Janssen Products, LP 2015-01-31
59676-0578-30 30 TABLET, FILM COATED in 1 BOTTLE (59676-578-30) PREZCOBIX Janssen Products, LP 2025-03-21
Observed labelers: Janssen Products, LP (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.